Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prestige Brands Visits Doctors To Cure Slumping Monistat Sales

This article was originally published in The Tan Sheet

Executive Summary

The firm in the second half of 2015 plans six initiatives to influence health care professionals on recommending Monistat for patients, CEO Matthew Mannelly says. Sales of Monistat have slid since a previous owner of the brand stopped marketing to health care professionals.

You may also be interested in...



Dentek Consumption Dip Slows Prestige Sales Despite Digestion, Eye Care Gains

Prestige Consumer Healthcare sales in North America in its latest quarter fell 3.9% as retailers slowed on orders of Dentek oral care products. Compound W and Nix lice treatment brands have ‘runway’ for long-term growth on line extensions and marketing.

Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning

Prestige Brands has $69m deal to divest its household cleaning business, its final non-OTC assets.. The firm will keep its “power core” OTC brands including Monistat, Summer’s Eve and Goody’s as its marketing focus.

Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning

Prestige Brands has $69m deal to divest its household cleaning business, its final non-OTC assets.. The firm will keep its “power core” OTC brands including Monistat, Summer’s Eve and Goody’s as its marketing focus.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS107491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel